Dr Erwan FOURN

D.U. Antibiologie - Université Paris 7 - Diderot

Doctorat en sciences médicales - Université de Bretagne Occidentale (UBO)

D.E.S. Médecine générale - Université de Bretagne Occidentale (UBO)

Praticien - Hôpital Foch - Suresnes - Médecine interne / Réseau Ville Hôpital / Unité de soins continus de chirurgie digestive

Praticien - Hôpital Bicêtre APHP - Le Kremlin-Bicêtre - Médecine interne

Membre du bureau - Réseau ville-hôpital Val-de-Seine

Decreased darunavir concentrations during once-daily co-administration with maraviroc and raltegravir: OPTIPRIM-ANRS 147 trial - Article

Acute hepatitis A breakthrough in MSM in Paris area: implementation of targeted hepatitis A virus vaccine in a context of vaccine shortage - Article

Increase in sexually transmitted infections in a cohort of outpatient HIV-positive men who have sex with men in the Parisian region - Article

Intensive five-drug antiretroviral therapy regimen versus standard triple-drug therapy during primary HIV-1 infection (OPTIPRIM-ANRS 147): a randomised, open-label, phase 3 trial - Article

Immunohematologic tolerance of chronic transfusion exchanges with erythrocytapheresis in sickle cell disease - Article

HIV-1 subtype B-infected MSM may have driven the spread of transmitted resistant strains in France in 2007-12: impact on susceptibility to first-line strategies - Article

Durability and Effectiveness of Maraviroc-Containing Regimens in HIV-1-Infected Individuals with Virological Failure in Routine Clinical Practice - Article

Combined ART started during acute HIV infection protects central memory CD4+ T cells and can induce remission - Article

A multifaceted intervention designed to improve medical management of Moderate to advanced chronic kidney disease in HIV-infected patients: a cluster randomized trial - Article

[Disseminated varicella-zoster virus infection with hemorrhagic gastritis during the course of chronic lymphocytic leukemia: case report and literature review] - Article

Very prolonged liposomal amphotericin B use leading to a lysosomal storage disease - Article

Clinical features and risk factors for atazanavir (ATV)-associated urolithiasis: a case-control study - Article

Long-term immunogenicity of two doses of 2009 A/H1N1v vaccine with and without AS03(A) adjuvant in HIV-1-infected adults - Article

Is clinical practice concordant with the changes in guidelines for antiretroviral therapy initiation during primary and chronic HIV-1 infection? The ANRS PRIMO and COPANA cohorts - Article

Associations between 25-hydroxyvitamin D and immunologic, metabolic, inflammatory markers in treatment-naive HIV-infected persons: the ANRS CO9 «COPANA» cohort study - Article

Switching to darunavir/ritonavir 800/100 mg once-daily containing regimen maintains virological control in fully suppressed pre-treated patients infected with HIV-1 - Article

Safety and immunogenicity of a monovalent 2009 influenza A/H1N1v vaccine adjuvanted with AS03A or unadjuvanted in HIV-infected adults: a randomized, controlled trial - Article

Déterminants de l'augmentation de l'épaisseur intima-média carotidienne chez le patient infecté par le VIH - Thèse